About the Journal

Focus and Scope

Progress in Drug Discovery & Biomedical Science (PDDBS) is an open access journal dedicated to the exchange of information and understandings about the research in areas of drug discovery and biomedical science based on the principles established through international conventions.

PDDBS covering both the fundamental and application aspects of drug discovery & biomedical science and welcoming papers having a good interdisciplinary approach.

Coverage includes:

-Plant, microbes bioactives

-Basic or applied biomedical research

-Toxicology & pharmacology

- Molecular/cell biology

- Drug delivery

- Therapeutic strategies/targets

- ADME

- Clinical trials

- Structural Biology and Biomolecular Modeling

- Curriculum, instruction and pedagogy

Publication Frequency

The publication frequency of Progress in Drug Discovery and Biomedical Science is annually.

Open Access Policy

Progress in Drug Discovery and Biomedical Science is a Gold Open access journal. Author(s) shall retain the copyright of their work, but grant to the Publisher a license to publish.

Progress in Drug Discovery and Biomedical Science works under the license of Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) that allows copying, distribution, and transmission of the published work with the acknowledgement of original creator. This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types.

Sources of Support

Progress in Drug Discovery and Biomedical Science is financially supported by Open-Access model system under the HH Publisher